Japanese Riken And Toppan Conduct Trials Using DNA To Select AIDS Drugs
This article was originally published in PharmAsia News
Executive Summary
Japanese Rikakaku Institute and printing company Toppan June 22 initiated a clinical trial in Thailand to forecast efficacy and adverse effects of AIDS drugs based on patient DNA types. The trial will use gene analysis device developed by Toppan subsidiary Rikan Genesis. The two companies aim to confirm the effectiveness of the device through the trials and market the product in Thailand where many AIDS patents are suffering adverse effects of AIDS drugs. (Click here for more - Japanese language